Home Search

prvb - search results

If you're not happy with the results, please do another search

Sanofi (SNY) to Acquire Provention Bio (PRVB) for $25 a Share. Gains 243%.

Up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of hard...

We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.

And up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of...

Provention Bio (PRVB) Gains 26% Last Week.

We're up 106% From Adding to the 2022 Watch List Last July. And up 26% a Week After Urging Holders to Calm...

FDA Approval for Provention Bio (PRVB).

Re-cork the Champagne! We were contemplating (dreaming) about an opening price over $12, and then a drift up...

Provention Biosciences (PRVB) Enters the Danger Zone.

Chart Looks Beautiful - But Nervous is why, we use soft and dry. LIVE QUOTE We'll...

Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital

Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval....
Provention Bio

Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.

This is in our 'Stocks we Hope to Double' Watch List. LIVE QUOTE

Provention (PRVB) Price Target $18.

Headline Says Downgrade, But That's Near 300% Higher From Here! LIVE QUOTE

Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.

Here's How Provention's Treatment Works. Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Provention

Provention Bio (PRVB) Updates.

LATEST UPDATE July 13th, 2022, below. (2021) We're getting way too many calls on...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...